Hongfang Sun

发表

Dual-Targeted Fe₃O₄@MnO₂ Nanoflowers for Magnetic Resonance Imaging-Guided Photothermal-Enhanced Chemodynamic/Chemotherapy for Tumor.

Huifang Xiao, S. Xie, Pingyu Wang, 2022, Journal of biomedical nanotechnology.

Oncogenic TRIB2 interacts with and regulates PKM2 to promote aerobic glycolysis and lung cancer cell procession

H. Zheng, S. Xie, Pingyu Wang, 2022, Cell Death Discovery.

Oncogenic TRIB2 interacts with and regulates PKM2 to promote aerobic glycolysis and lung cancer cell procession

H. Zheng, S. Xie, Pingyu Wang, 2022, Cell death discovery.

MiR‐138‐5p suppresses the progression of lung cancer by targeting SNIP1

S. Xie, Pingyu Wang, You-jie Li, 2023, Thoracic cancer.

WFDC21P promotes triple-negative breast cancer proliferation and migration through WFDC21P/miR-628/SMAD3 axis

S. Xie, Pingyu Wang, You-jie Li, 2022, Frontiers in Oncology.

MiR-10a-5p: A Promising Biomarker for Early Diagnosis and Prognosis Evaluation of Bladder Cancer

Hong-Fang Sun, Lei Yang, Lingxiang Guo, 2021, Cancer management and research.

NDRG3 regulates imatinib resistance by promoting β‑catenin accumulation in the nucleus in chronic myelogenous leukemia

S. Xie, Pingyu Wang, You-jie Li, 2023, Oncology Report.

TRIB2 regulates the expression of miR-33a-5p through the ERK/c-Fos pathway to affect the imatinib resistance of chronic myeloid leukemia cells

S. Xie, You-jie Li, Ranran Wang, 2022, International journal of oncology.

NDRG3 regulates imatinib resistance by promoting β‑catenin accumulation in the nucleus in chronic myelogenous leukemia

S. Xie, Pingyu Wang, You-jie Li, 2023, Oncology reports.

Advancements in Stimulus-Responsive Co-Delivery Nanocarriers for Enhanced Cancer Immunotherapy

Hongfang Sun, Qin Wang, Meng-Ru Zhang, 2024, International journal of nanomedicine.